Sarcocystis species are single-celled, protozoan parasites that infect various vertebrate hosts, cycling between predatory and prey animals, and causing sarcocystosis, a tissue-invasive infection.
Hyperbaric oxygen therapy may offer potential benefits in treating Sarcocystis species by enhancing the immune response, reducing inflammation, and inhibiting the parasite’s growth and reproduction.